[go: up one dir, main page]

AR011517A1 - Analogos proteicos relacionados con la hormona paratiroides - Google Patents

Analogos proteicos relacionados con la hormona paratiroides

Info

Publication number
AR011517A1
AR011517A1 ARP980100058A ARP980100058A AR011517A1 AR 011517 A1 AR011517 A1 AR 011517A1 AR P980100058 A ARP980100058 A AR P980100058A AR P980100058 A ARP980100058 A AR P980100058A AR 011517 A1 AR011517 A1 AR 011517A1
Authority
AR
Argentina
Prior art keywords
acc
cha
leu
phe
aib
Prior art date
Application number
ARP980100058A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of AR011517A1 publication Critical patent/AR011517A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Análogos proteicos relacionados con la hormona paratiroides, que comprende la formula (I), donde: A1 es Ser, Ala o Dap; A3 es Ser, Thr o Aib; A5 es Leu,Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3;A 7 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3; A8 es Met, Nva, Leu, Val, Ile, Cha, Acc, o Nle; A11 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, dondeX es OH, un halogeno, o CH3;A1 2 es Gly, Acc, o Aib; A15 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3; A16es Ser, Asn, Ala o Aib; A18 es Met, Nva, Leu, Val, Ile, Nle, Acc, Cha o Aib; A19 es Glu o Aib; A21 es Val, Acc, Cha oMet ; A22 es Acc o Glu; A23 es Trp,Acc, o Cha; A24 es Leu, Acc, o Cha; A27 es Lys, Aib, Leu, hArg, Gln, Acc, o Cha; A28 es Leu, Acc, o Cha; A29 es Glu, Acc, o Aib; A30 es Aps, o Lys; A31es Val, Leu, Nle, Acc, Cha o está suprimido; A32 es His oestá s uprimido; A33 es Ans o está suprimido; A34 es Phe, Tyr, Amp, Aib o está suprimido; cada unode R1 o R2 es, en forma independiente, H, alquilo C1-12, alquenilo, C2-12, fenilalquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12,hidroxialquil oC2-12; hidroxifenilalquilo C7-20; o hidroxinaftilalquilo C11-20; o uno y solamente uno de R1 y R2 es COE1, donde E1 es alquilo C1-12, alquenilo C2-12,fenialquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12,hidroxialquenilo C2-12, hidro xifenilalquilo C7-20, hidroxinaftilalquilo C11-20; y R3 es OH, NH2,alcoxi C1-12, o NH- Y - CH2 -Z, donde Y, es una porcion de hidrocarburo C1-12; y Z es H, OH, CO2H, o CONH2; siempre y cuando al menos uno de A5, A7,A8, A11,A12, A15, A18, A21, A22, A23, A24, A27, A28, A29, y A31 sea Acc; o una sal farmacéuticamente aceptable de los mismos.
ARP980100058A 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides AR011517A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone

Publications (1)

Publication Number Publication Date
AR011517A1 true AR011517A1 (es) 2000-08-30

Family

ID=27119618

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980100058A AR011517A1 (es) 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides
ARP030100515A AR038552A2 (es) 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030100515A AR038552A2 (es) 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Country Status (23)

Country Link
US (1) US5955574A (es)
EP (3) EP2206725A1 (es)
JP (1) JP3963482B2 (es)
KR (2) KR100497709B1 (es)
CN (1) CN1137898C (es)
AR (3) AR011517A1 (es)
AT (2) ATE471342T1 (es)
AU (1) AU741584B2 (es)
BR (1) BR9714200A (es)
CA (1) CA2276614C (es)
CZ (2) CZ301497B6 (es)
DE (2) DE69735603T2 (es)
DK (2) DK1645566T3 (es)
ES (2) ES2258286T3 (es)
HU (1) HUP9904596A3 (es)
IL (1) IL130794A0 (es)
NO (1) NO993341L (es)
NZ (1) NZ336610A (es)
PL (1) PL191898B1 (es)
PT (2) PT1645566E (es)
RU (1) RU2198182C2 (es)
SI (2) SI1645566T1 (es)
WO (1) WO1998030590A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
ATE297754T1 (de) 1997-09-09 2005-07-15 Hoffmann La Roche Heilung von bruchverletzungen unter verwendung von pthrp analogen
ATE392431T1 (de) * 1998-05-05 2008-05-15 Sod Conseils Rech Applic Pth2 rezeptor selektive verbindungen
PL345583A1 (en) * 1998-07-20 2001-12-17 Sod Conseils Rech Applic Peptide analogues of pacap
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6489297B1 (en) 2000-02-18 2002-12-03 Dabur Research Foundation Vasoactive intestinal peptide analogs
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
ATE356631T1 (de) 2001-06-01 2007-04-15 Novartis Pharma Gmbh Orale verabreichung von parathyroidhormon und calcitonin
JP4837888B2 (ja) 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン(pth)類似体
CA2534577A1 (en) * 2003-08-06 2005-02-24 Rhodia, Inc. Method for promoting bone growth
AU2006315132A1 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
RS56164B1 (sr) * 2006-10-03 2017-11-30 Radius Health Inc Stabilna kompozicija koja sadrži pthrp i njene upotrebe
PL2084183T3 (pl) * 2006-10-13 2010-10-29 Lilly Co Eli Pegylowane pth jako modulatory receptora pth i ich zastosowania
CN104072606B (zh) 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
MX342898B (es) 2010-05-12 2016-10-18 Radius Health Inc * Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
KR101900078B1 (ko) 2010-05-13 2018-09-18 더 제너럴 하스피탈 코포레이션 부갑상선 호르몬 아날로그 및 그의 용도
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
SI3122426T1 (sl) 2014-03-28 2023-04-28 Duke University Zdravljenje raka dojk z uporabo selektivnih modulatorjev estrogenskih receptorjev
IL255189B2 (en) 2015-04-29 2024-04-01 Radius Pharmaceuticals Inc A combination of rad1901 and a cdk4/6 inhibitor for use in treating cancer
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
CA3027563C (en) 2016-06-22 2024-07-02 Ellipses Pharma Ltd AR+ METHODS FOR BREAST CANCER TREATMENT
ES2981967T3 (es) 2017-01-05 2024-10-14 Radius Pharmaceuticals Inc Formas polimórficas de RAD1901-2HCl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl
PH12021551950A1 (en) 2019-02-12 2022-05-23 Radius Pharmaceuticals Inc Processes and compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
WO1990010067A1 (de) * 1989-02-23 1990-09-07 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CZ293425B6 (cs) 1993-01-06 2004-04-14 Kinerton Limited Polyester obsahující jednu nebo více volných karboxylových skupin a přípravek tento polyester obsahující
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CA2205959A1 (en) * 1994-12-19 1996-06-27 Michael Chorev Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
AR051906A2 (es) 2007-02-14
NO993341L (no) 1999-09-06
CN1137898C (zh) 2004-02-11
HUP9904596A1 (hu) 2000-06-28
WO1998030590A3 (en) 1998-12-10
EP1645566B1 (en) 2010-06-16
DK0948541T3 (da) 2006-07-17
ES2258286T3 (es) 2006-08-16
ES2347154T3 (es) 2010-10-26
HUP9904596A3 (en) 2000-07-28
CZ298937B6 (cs) 2008-03-19
KR100699422B1 (ko) 2007-03-28
NZ336610A (en) 2001-07-27
KR100497709B1 (ko) 2005-06-23
DE69735603D1 (de) 2006-05-18
DK1645566T3 (da) 2010-09-27
SI1645566T1 (sl) 2010-11-30
CA2276614A1 (en) 1998-07-16
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
WO1998030590A9 (en) 1999-08-19
PT1645566E (pt) 2010-08-31
AR038552A2 (es) 2005-01-19
BR9714200A (pt) 2000-03-28
ATE321784T1 (de) 2006-04-15
JP2001508439A (ja) 2001-06-26
SI0948541T1 (sl) 2006-06-30
DE69735603T2 (de) 2006-11-30
AU741584B2 (en) 2001-12-06
CA2276614C (en) 2002-06-11
CN1254347A (zh) 2000-05-24
EP0948541A2 (en) 1999-10-13
ATE471342T1 (de) 2010-07-15
JP3963482B2 (ja) 2007-08-22
EP1645566A2 (en) 2006-04-12
HK1026215A1 (en) 2000-12-08
KR20060030006A (ko) 2006-04-07
IL130794A0 (en) 2001-01-28
PT948541E (pt) 2006-07-31
EP2206725A1 (en) 2010-07-14
WO1998030590A2 (en) 1998-07-16
EP0948541B1 (en) 2006-03-29
KR20000069952A (ko) 2000-11-25
DE69739912D1 (de) 2010-07-29
PL334438A1 (en) 2000-02-28
AU5519998A (en) 1998-08-03
CZ239899A3 (cs) 2000-01-12
US5955574A (en) 1999-09-21
CZ301497B6 (cs) 2010-03-24
EP1645566A3 (en) 2006-10-11
RU2198182C2 (ru) 2003-02-10

Similar Documents

Publication Publication Date Title
AR011517A1 (es) Analogos proteicos relacionados con la hormona paratiroides
AR019131A1 (es) Analogos de polipeptidos pituitarios que activan la adenilato ciclasa, una composicion farmaceutica que los comprende, y el uso de dichos peptidos para lamanufactura de un medicamento
ES2329233T3 (es) Analogos de la hormona paratiroidea.
RU99117145A (ru) Аналоги гормона паращитовидной железы
US20070299009A1 (en) Analogs of parathyroid hormone
US6921750B2 (en) Analogs of parathyroid hormone
CA2292846A1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
AR073099A2 (es) Analogos de ghrelina
ATE69821T1 (de) Grf-analoga.
BR9913457A (pt) Neuroproteção
DE69938064D1 (de) Aminoterminal modifizierte parathyroidhormon (pth) analoge
PT96135A (pt) Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao
SE9302124D0 (sv) Biologically active vasopressin analogues
DK0585444T3 (da) Behandling af hepatomer med somatostatinanaloger
ES8701784A1 (es) Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina
NZ335879A (en) Somatostatin antagonist peptides having a D-amino acid at the second residue
BR9812404A (pt) Combinação de um antagonista de endotelina, preparação farmacêutica, processo para preparar uma preparação farmacêutica, e , uso de uma combinação de um bloqueador de beta receptor e de um antagonista de endotelina
BR0011680A (pt) Agonistas receptores de somatostatina neuromedina b, seu uso e composição farmacêutica compreendendo os mesmos
Lariviere et al. Complete Sequence of the glycosylated amino terminal segment of porcine pro‐opiomelanocortin
ES8707740A1 (es) Un procedimiento para preparar octapeptidos ciclicos
CA2226177A1 (en) Analogs of parathyroid hormone
DK0737691T3 (da) Bombesinanaloger
PE20061419A1 (es) Agonistas del receptor (vpac2) de peptido activador de adenilato ciclasa hipofisaria (pacap)
MX9303970A (es) COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO.
EP0234935A3 (en) Vasopressin compounds

Legal Events

Date Code Title Description
FG Grant, registration